充血性心力衰竭治疗进展

被引:6
作者
柯元南
机构
[1] 中日友好医院心内科
关键词
充血性心力衰竭; 洋地黄; 利尿药; 血管扩张药; 血管紧张素转换酶抑制药; 醛固酮拮抗药; β受体阻断药;
D O I
暂无
中图分类号
R541.61 [];
学科分类号
1002 ; 100201 ;
摘要
充血性心力衰竭是各 种心脏病的终末阶段,其预后较差。近20年来充血性心力衰竭的治疗进入神经体液调节时代。在洋地黄、利尿药和血管扩张药的基础上,使用血管紧张素转换酶抑制药、β受体阻断剂、醛固酮拮抗剂等,已取得初步成功,但尚未根本改变充血性心力衰竭的预后。
引用
收藏
页码:23 / 26
页数:4
相关论文
共 3 条
[1]  
Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF)[J] . The Lancet . 1999 (9169)
[2]  
Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)[J] . Bertram Pitt,Robert Segal,Felipe A Martinez,Georg Meurers,Alan J Cowley,Ignatius Thomas,Prakash C Deedwania,Dawn E Ney,Duane B Snavely,Paul I Chang.The Lancet . 1997 (9054)
[3]  
Congestive Heart Failure/Myocardial Disease: Carvedilol Produces Dose-Related Improvements in Left Ventricular Function and Survival in Subjects With Chronic Heart Failure[J] . Michael R. Bristow,Edward M. Gilbert,William T. Abraham,Kirkwood F. Adams,Michael B. Fowler,Ray E. Hershberger,Spencer H. Kubo,Kenneth A. Narahara,Henry Ingersoll,Steven Krueger,Sarah Young,Neil Shusterman.Circulation . 1996 (11)